11 dead, 41 hurt as suicide bombers hit Indonesian churches

Agencies
May 13, 2018

Surabaya, May 13: Suicide bombers on motorcycles and including a woman with children targeted today Mass congregations in three churches in Indonesia's second largest city, killing at least 11 people and wounding dozens in one of the worst attacks on the Christian minority, police said.

The first attack struck the Santa Maria Roman Catholic Church in Surabaya, killing four people, including one or more bombers, police spokesman Frans Barung Mangera told reporters at the scene. He said two police officers were among a total of 41 wounded.

The blast was followed by a second explosion minutes later at the Christian Church of Diponegoro and a third at the city's Pantekosta Church, Mangera said.

President Joko "Jokowi" Widodo arrived in Surabaya, the East Java provincial capital, in the aftermath of the attacks, Mangera said. The bombings were the worst since a series of attacks on churches on Christmas Eve in 2000 killed 15 people and wounded nearly 100. Religious minorities, especially Christians, have been repeatedly targeted by militants.

A senior police official said the bombings were carried out by at least five suicide bombers, including a veiled woman who had two children with her. The official spoke on condition of anonymity because he wasn't authorized to speak to the media.

A witness described the woman with children, saying she was carrying two bags at the Diponegoro church.

"At first officers blocked them in front of the churchyard but the woman ignored and forced her way inside. Suddenly she hugged a civilian then (the bomb) exploded," said a civilian guard named Antonius.

Shattered glass and chunks of concrete littered the entrance of the Santa Maria Church, which was sealed off by heavily armed police. Rescue personnel treated victims on a nearby field while officers inspected wrecked motorcycles in the parking lot that were burned in the explosion.

A street merchant outside the church said she was blown away several meters (yards) by the powerful blast.

"I saw two men riding a motorbike forced their way into the churchyard. One was wearing black pants and one with a backpack," said Samsia, who uses a single name. "Soon after that the explosion happened." In Jakarta, the Indonesian Church Association strongly condemned the attacks and called on people to wait on authorities to investigate.

"We are angry with these attacks, but we leave it to the authorities to resolve them," said Gormar Gultom, an official with the association.

National police spokesman Setyo Wasisto announced that police fatally shot four suspected militants and arrested two others early Sunday in West Java towns. It wasn't clear if the shootings were connected with the church attacks.

"They have trained in order to attack police," Wasisto said, identifying the militants as members of Jemaah Anshorut Daulah, or JAD. The network of about two dozen extremist groups has been implicated in a number of attacks in Indonesia over the past year. It pledges allegiance to Islamic State group leader Abu Bakr al-Baghdadi.

The latest attacks in predominantly Muslim Indonesia came days after police ended a riot and hostage-taking at a detention center near Jakarta that left six officers and three inmates dead. The Islamic State group has claimed responsibility.

Indonesia has carried out a sustained crackdown on militants since bombings by al-Qaida-affiliated radicals in Bali in 2002 killed 202 people. In recent years, the country has faced a new threat as the rise of the Islamic State group in the Middle East invigorated local militant networks.

Christians, many of whom from the ethnic Chinese minority, make up about 9 per cent of Indonesia's 260 million people.

Comments

mark sebastin
 - 
Sunday, 13 May 2018

jihadists are curse to the whole world  .. RIP bro and sisters.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 4,2020

Beijing, Jun 4: Around 40 students and staff members of a primary school in China were stabbed by a security guard, official media reported today.

The incident happened at a school in China's Guangxi province, state-run China Daily said in a brief report.

Further details about the attack are awaited.

Knife attacks by disgruntled people have been taking place in different parts of China in the past few years, reported news agency Press Trust of India.

The attackers targeted mainly kindergarten and primary schools besides public transport, the news agency reported.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 24,2020

Toronto, Apr 25: Canadian Prime Minister Justin Trudeau on Thursday (local time) announced a new CAD 1.1 billion package supporting vaccine research and clinical trials as well as expanded testing capacity.

"We are putting in place an additional CAD 1.1 billion dollars for a national medical and research strategy to address COVID-19," Trudeau said during his daily novel coronavirus pandemic briefing on Thursday.

"This plan has three pillars -- research on vaccines and other treatments, support for clinical trials and expanding national testing and modelling," he added.

Trudeau pointed out that CAD 82 million of the total sum will be directed to the development of a vaccine and treatments against the virus, while CAD 471 million will go towards supporting clinical trials.

A further CAD 249 million is being allocated for expanding testing capacity and modelling, the Prime Minister added.

According to Trudeau, this funding will be allotted to a new "immunity task force" commissioned with conducting serology testing -- blood tests looking for the presence of antibodies indicative of exposure to the virus and subsequent immune response.

He said the taskforce, comprising the country's top medical experts, including Chief Public Health Officer Dr Theresa Tam, will test at least a million Canadians over the next two years.

The funding announced today comes in addition to the CAD 200 million committed for COVID-19-related research on March 11.

Trudeau has repeatedly stressed the daily constraints that much of the population is adhering to will be the new normal until a vaccine is developed.

As of Thursday, Canada has confirmed a total of 40,824 COVID-19 cases since the onset of the outbreak, out of which more than 2,000 have proven to be fatal, according to the latest figures from the country's public health agency.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

May 19: A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.

The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.

Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.

"That means this potential drug has (a) therapeutic effect."

The drug uses neutralising antibodies -- produced by the human immune system to prevent the virus infecting cells -- which Xie's team isolated from the blood of 60 recovered patients.

A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.

Xie said his team had been working "day and night" searching for the antibody.

"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."

He added that the drug should be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

"Planning for the clinical trial is underway," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.

"The hope is these neutralised antibodies can become a specialised drug that would stop the pandemic," he said.

China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.

But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma -- a blood fluid -- from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.

More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".

"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).

Xie said his researchers had "an early start" since the outbreak started in China before spreading to other countries.

Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 -- clinical trials in the US showed it shortened the recovery time in some patients by a third -- but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.

The study showed that if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".

More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

"We would be able to stop the pandemic with an effective drug, even without a vaccine," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.